Utilization of common inflammatory markers in new, symptomatic, primary care outpatients based on their cost-effectiveness

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 5, 2003, Pages 668-674

  Takemura, Yuzuru ^a   Ishida, Haku ^b   Inoue, Yuji ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

C reactive protein; Cost effectivenes; Inflammatory markers; New outpatients; Primary care practice; Sialic acid

Indexed keywords

C REACTIVE PROTEIN; SIALIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOANALYZER; CLINICAL PRACTICE; CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; OUTPATIENT CARE; PREDICTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; BIOLOGICAL MARKERS; CHILD; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INFLAMMATION; LABORATORY TECHNIQUES AND PROCEDURES; MALE; MIDDLE AGED; OUTPATIENTS;

EID: 0038680231     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.101     Document Type: Article

References (22)

1. Plebani M, Piva E. Erythrocyte sedimentation rate: use of fresh blood for quality control. Am J Clin Pathol 2002; 117:621-6.
2. Brigden ML. The erythrocyte sedimentation rate: still a helpful test when used judiciously. Postgrad Med 1998; 103:257-74.
3. Saadeh C. The erythrocyte sedimentation rate: old and new clinical application. South Med J 1998; 91:220-5.
4. Sox HC Jr, Liang MH. The erythrocyte sedimentation rate: guidelines for rational use. In: Sox HC Jr, editor. Common diagnostic tests: use and interpretation, 2nd ed. Philadelphia: American College of Physicians, 1990:204-26.
5. Hashimoto N. Essential laboratory tests (a proposal). In: Subcommittee of "The Uses of Clinical Laboratory Tests in Daily Primary Medical Care", the Japan Society of Clinical Pathology, edition. The uses of clinical laboratory tests in daily primary medical care, 1st ed. Tokyo: The Japan Society of Clinical Pathology, 1989:1-16.
6. Takemura Y, Matsuta H, Kugai N, Sekiguchi S. Application of inflammation markers in the "Essential Laboratory Tests" to new outpatients and analysis for the efficacious selection of these items [in Japanese with English abstract]. Rinsho Byori (Jpn J Clin Pathol) 1994; 42:1055-61.
7. Araki H, Yamada M. Sialic acid. In: Bergmeyer HU, editor. Methods of enzymatic analysis, Vol. 6, 3rd ed. Weinheim: Verlag Chemie, 1984:80-90.
8. Kalela A, Pönniö M, Koivu TA, Höyhtyä M, Huhtala H, Sillanaukee P, et al. Association of serum sialic acid and MMP-9 with lipids and inflammatory markers. Eur J Clin Invest 2000; 30:99-104.
9. Sillanaukee P, Pönniö M, Jääskeläinen IP. Occurrence of sialic acid in healthy humans and different disorders. Eur J Clin Invest 1999; 29:413-25.
10. Pepys MB. C-reactive protein. A review of its structure and function. Eur J Rheumatol Inflamm 1982; 5:386-97.
11. Taniuchi K, Chifu K, Hayashi N, Nakamachi Y, Yamaguchi N, Miyamoto Y, et al. A new enzymatic method for the determination of sialic acid in serum and its application for a marker of acute phase reactants. Kobe J Med Sci 1981; 27:91-102.
12. Stefenelli N, Klotz H, Engel A, Bauer P. Serum sialic acid in malignant tumours, bacterial infections and chronic liver diseases. J Cancer Res Clin Oncol 1985; 109:55-9.
13. Morishita Y, Nakane K, Kosaka A. Determination and clinical evaluation of sialic acids in serum [in Japanese]. Rinsho Byori (Jpn J Clin Pathol) 1976; 24:411-4.
14. Sugahara K, Sugimoto K, Nomura O, Usui T. Enzymatic assay of serum sialic acid. Clin Chim Acta 1980; 108:493-8.
15. Crook M. The determination of plasma or serum sialic acid. Clin Biochem 1993; 26:31-8.
16. Takemura Y, Ishida H, Inoue Y, Beck JR. Common diagnostic test panels for clinical evaluation of new primary care outpatients in Japan: a cost-effectiveness evaluation. Clin Chem 1999; 45:1752-61.
17. Takemura Y, Ishida H, Inoue Y, Kobayashi H, Beck JR. Opportunistic discovery of occult disease by use of test panels in new, symptomatic primary care outpatients: yield and cost of case finding. Clin Chem 2000; 46:1091-8.
18. Takemura Y, Ishida H, Inoue Y, Beck JR. Yield and cost of individual common diagnostic tests in new primary care outpatients in Japan. Clin Chem 2002; 48:42-54.
19. Takemura Y, Ishida H, Inoue Y, Beck JR. A cost-effectiveness analysis of a pre-visit testing system for new outpatients in primary care medicine [in Japanese with English abstract]. Rinsho Byori (Jpn J Clin Pathol) 2000; 48:269-75.
20. Takemura Y, Kobayashi H, Kugai N, Sekiguchi S. The results of the "Essential Laboratory Tests" applied to new outpatients - re-evaluation of diagnostic efficiencies of the test items. Jpn J Clin Pathol 1996; 44:555-63.
21. Kosaka A, Matsumoto H, Ohori M. Evaluation of correlation between serum sialic acid and various serum specific proteins [in Japanese]. Rinsho Byori (Jpn J Clin Pathol) 1988; 36:679-84.
22. Crook MA, Haq M, Tutt P. Serum sialic acid and its relationship to various haematological parameters, including erythrocyte sedimentation rate. Br J Biomed Sci 1997; 54: 100-3.